`Patent Owner’s Fourth Updated Mandatory Notices
`
`Filed on behalf of Patent Owner Genentech, Inc. by:
`
`
`David L. Cavanaugh (Reg. No. 36,476)
`Lauren V. Blakely (Reg. No. 70,247)
`Robert J. Gunther, Jr. (Pro Hac Vice)
`Lisa J. Pirozzolo (Pro Hac Vice)
`Kevin S. Prussia (Pro Hac Vice)
`Andrew J. Danford (Pro Hac Vice)
`WILMER CUTLER PICKERING
`HALE AND DORR LLP
`1875 Pennsylvania Ave., NW
`Washington, DC 20006
`
`
`
`
`
`Adam R. Brausa (Reg No. 60,287)
`Daralyn J. Durie (Pro Hac Vice)
`DURIE TANGRI LLP
`217 Leidesdorff Street
`San Francisco, CA 94111
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`PFIZER, INC., AND
`SAMSUNG BIOEPIS CO., LTD.,
`Petitioners,
`
`v.
`
`GENENTECH, INC.,
`Patent Owner.
`
`Case IPR2017-01489
`U.S. Patent 6,407,213
`
`
`
`PATENT OWNER’S FOURTH UPDATED MANDATORY NOTICES
`UNDER 37 C.F.R. §42.8
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2017-01489
`Patent Owner’s Fourth Updated Mandatory Notices
`
`Patent Owner Genentech, Inc. hereby files fourth updated mandatory notices
`
`
`
`pursuant to 37 C.F.R. § 42.8.
`
`I.
`
`
`REAL PARTY IN INTEREST
`No change.
`
`II. RELATED MATTERS
`Pursuant to 37 C.F.R. § 42.8(b)(2), Patent Owner identifies the following
`
`matters that may relate to U.S. Application No. 08/146,206, which issued as U.S.
`
`Patent No. 6,407,213:
`
` U.S. Patent No. 6,407,213 is the patent at issue in Samsung Bioepis Co., Ltd.
`
`v. Genentech, Inc., IPR2017-02140, which has been joined with this
`
`proceeding;
`
` U.S. Patent No. 6,407,213 is the patent at issue in Pfizer, Inc. v. Genentech,
`
`Inc., IPR2017-01488, which is pending;
`
` U.S. Patent No. 6,407,213 is the patent at issue in Samsung Bioepis Co., Ltd.
`
`v. Genentech, Inc., IPR2017-02139, which has been joined with Pfizer, Inc.
`
`v. Genentech, Inc., IPR2017-01488;
`
` U.S. Patent No. 6,407,213 is the patent at issue in Celltrion, Inc. v.
`
`Genentech, Inc., IPR2017-01373, which is pending;
`
` U.S. Patent No. 6,407,213 is the patent at issue in Celltrion, Inc. v.
`
`Genentech, Inc., IPR2017-01374, which is pending;
`
`
`
`- 2 -
`
`
`
`IPR2017-01489
`Patent Owner’s Fourth Updated Mandatory Notices
`
` U.S. Patent No. 6,407,213 was the patent at issue in Boehringer Ingelheim
`
`Pharmaceuticals, Inc. v. Genentech, Inc., IPR2017-02031, which has been
`
`terminated and adverse judgment entered; and
`
` U.S. Patent No. 6,407,213 was the patent at issue in Boehringer Ingelheim
`
`Pharmaceuticals, Inc. v. Genentech, Inc., IPR2017-02032, which has been
`
`terminated and adverse judgment entered;
`
` U.S. Patent No. 6,407,213 was the patent at issue in Mylan Pharmaceuticals
`
`Inc. v. Genentech, Inc., IPR2016-01693, which has been terminated;
`
` U.S. Patent No. 6,407,213 was the patent at issue in Mylan Pharmaceuticals
`
`Inc. v. Genentech, Inc., IPR2016-01694, which has been terminated;
`
` U.S. Patent No. 6,407,213 is a patent at issue in Genentech, Inc. et al. v.
`
`Pfizer, Inc. (D. Del.) 1:17-cv-01672, which is pending;
`
` U.S. Patent No. 6,407,213 is a patent at issue in Celltrion, Inc. et al. v.
`
`Genentech, Inc. et al. (N.D. Cal.) No. 18-cv-00274, which was dismissed;
`
` U.S. Patent No. 6,407,213 is a patent issue in Genentech, Inc. et al. v.
`
`Celltrion, Inc. et al. (D. Del.) No. 18-cv-00095, which is pending;
`
` U.S. Patent No. 6,407,213 is a patent at issue in Genentech, Inc. et al. v.
`
`Amgen Inc. (D. Del.) 1:18-cv-00924, which is pending;
`
` U.S. Patent No. 6,407,213 is a patent at issue in Genentech, Inc. et al. v.
`
`Celltrion, Inc. et al. (D. Del.) 1:18-cv-01025, which is pending;
`- 3 -
`
`
`
`
`
`
`
`
`
`IPR2017-01489
`Patent Owner’s Fourth Updated Mandatory Notices
`
` U.S. Patent No. 6,407,213 is a patent at issue in Genentech, Inc. et al. v.
`
`Samsung Bioepis Co., Ltd. (D. Del.) 1:18-cv-01373, which is pending;
`
` U.S. Patent No. 6,407,213 is a patent at issue in Celltrion, Inc. et al. v.
`
`Genentech, Inc. et al. (Fed. Cir.) No. 2018-2160, which is pending;
`
` U.S. Patent No. 6,407,213 is a patent at issue in Genentech, Inc. et al. v.
`
`Amgen Inc. (D. Del.) No. 1:17-cv-01407, which is pending.
`
` U.S. Patent No. 6,407,213 is a patent at issue in Amgen Inc. v. Genentech,
`
`Inc. et al. (C.D. Cal.) No. 2:17-cv-07349, which has been dismissed.
`
` U.S. Patent No. 6,407,213 is a patent at issue in Genentech, Inc. et al. v.
`
`Amgen Inc. (D. Del.) No. 1:17-cv-01471, which is pending.
`
`Patent Owner does not concede that any of the above-identified proceedings
`
`would affect, or be affected by, a decision in the present inter partes review.
`
`III. COUNSEL
`
`No change.
`
`IV. SERVICE INFORMATION
`No change.
`
`
`Date: September 19, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`- 4 -
`
`
`Respectfully submitted,
`
`By: /David L. Cavanaugh/
`David L. Cavanaugh
`Registration No. 36,476
`
`
`
`IPR2017-01489
`Patent Owner’s Fourth Updated Mandatory Notices
`
`
`
`WILMER CUTLER PICKERING HALE AND DORR LLP
`1875 PENNSYLVANIA AVENUE NW
`WASHINGTON, DC 20006
`TEL: 202-663-6025
`FAX: 202-663-6363
`EMAIL: david.cavanaugh@wilmerhale.com
`
`
`
`
`
`
`- 5 -
`
`
`
`IPR2017-01489
`Patent Owner’s Fourth Updated Mandatory Notices
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that, on September 19, 2018, I caused a true and correct
`
`
`
`
`
`
`copy of the following materials:
`
` Patent Owner’s Fourth Updated Mandatory Notices Under 37 C.F.R. §42.8
`
`to be served via electronic mail on the following attorneys of record:
`
`Amanda Hollis
`KIRKLAND & ELLIS LLP
`amanda.hollis@kirkland.com
`300 North LaSalle, Chicago, IL 60654
`
`Stefan M. Miller, Ph.D.
`Stefan.miller@kirkland.com
`601 Lexington Avenue, New York, NY 10022
`
`Benjamin A. Lasky
`benjamin.lasky@kirkland.com
`601 Lexington Avenue, New York, NY 10022
`
`Sarah K. Tsou
`sarah.tsou@kirkland.com
`601 Lexington Avenue, New York, NY 10022
`
`Mark C. McLennan
`mark.mclennan@kirkland.com
`601 Lexington Avenue, New York, NY 10022
`
`Christopher J. Citro
`christopher.citro@kirkland.com
`601 Lexington Avenue, New York, NY 10022
`
`Micah Rappazzo
`micah.rappazzo@kirkland.com
`601 Lexington Avenue, New York, NY 10022
`
`i
`
`
`
`
`
`
`
`
`
`
`
`IPR2017-01489
`Patent Owner’s Fourth Updated Mandatory Notices
`
`Sharick Naqi
`sharick.naqi@kirkland.com
`300 North LaSalle, Chicago, IL 60654
`
`Pfizer_Genentech_IPRs@kirkland.com
`
`Dimitrios T. Drivas
`WHITE & CASE LLP
`ddrivas@whitecase.com
`1221 Avenue of the Americas, New York, NY 10020
`
`Scott T. Weingaertner
`WHITE & CASE LLP
`scott.weingaertner@whitecase.com
`1221 Avenue of the Americas, New York, NY 10020
`
`Amit H. Thakore
`WHITE & CASE LLP
`athakore@whitecase.com
`1221 Avenue of the Americas, New York, NY 10020
`
`Eric Majchrzak
`WHITE & CASE LLP
`eric.majchrzak@whitecase.com
`1221 Avenue of the Americas, New York, NY 10020
`
`
`/Lauren V. Blakely/
`Lauren V. Blakely
`Reg. No. 70,247
`WILMER CUTLER PICKERING HALE
`AND DORR LLP
`950 Page Mill Road
`Palo Alto, CA 94304
`(650) 600-5039
`
`ii
`
`